Skip to main navigation
 

CytomX

 
  • About
    • Overview
    • Vision & Mission
    • Our Values
    • Executive Team
    • Board of Directors
    • Contact Us
  • Probody Therapeutics
    • Our Probody Approach
    • How Probody Therapeutics Work
    • A Versatile Platform
    • Scientific Publications & Presentations
  • Pipeline
    • Advancing a Pipeline
    • Lead Candidates
    • Clinical Trials
    • Access for HCPs/Patients
  • Partners
    • Opportunities
    • Current Partners
  • Investors & News
    • Corporate Profile
    • Press Releases
    • Events & Presentations
    • Scientific Publications
    • Corporate Governance
    • Stock Information
    • Financials & Filings
    • Analyst Coverage
    • Investor Resources
  • Culture & Careers
    • Overview
    • Xtraordinary Culture
    • Current Openings
    • Total Rewards Program
    • Corporate Amenities
Menu

Exciting things are happening here

Event Details

BTIG Biotechnology Conference 2022

Aug 9, 2022

  • Corporate Profile
  • Press Releases
  • Events and Presentations
  • Scientific Publications
  • Corporate Governance
  • Stock Information
  • Financials & Filings
  • Analyst Coverage
  • Investor Resources
  • Investor Tools

  • Print Page
  • Email Page
  • RSS Feeds
  • Email Alerts
  • Contact IR

Contact Us

151 Oyster Point Blvd, Suite 400

South San Francisco, CA

94080-1913

IR@CytomX.com

Share

Linkedin Twitter © CYTOMX INC | CYTOMX, our corporate logo, IHZ, and PROBODY are trademarks of CytomX Therapeutics, Inc. All other brands and trademarks referenced herein are the property of their respective owners.
  • About
    • Overview
    • Vision & Mission
    • Our Values
    • Executive Team
    • Board of Directors
    • Contact Us
  • Probody Therapeutics
    • Our Probody Approach
    • How Probody Therapeutics Work
    • A Versatile Platform
    • Scientific Publications & Presentations
  • Pipeline
    • Advancing a Pipeline
    • Lead Candidates
    • Clinical Trials
    • Access for HCPs/Patients
  • Partners
    • Opportunities
    • Current Partners
  • Investors & News
    • Corporate Profile
    • Press Releases
    • Events & Presentations
    • Scientific Publications
    • Corporate Governance
    • Stock Information
    • Financials & Filings
    • Analyst Coverage
    • Investor Resources
  • Culture & Careers
    • Overview
    • Xtraordinary Culture
    • Current Openings
    • Total Rewards Program
    • Corporate Amenities
  • Home
    • Terms of Use
    • Privacy Policy